Enzo Biochem Inc
(ENZB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 07/31
| 07-2021 | 04-2021 | 01-2021 | 10-2020 | 07-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 13,524 | 15,089 | 44,536 | 45,914 | 47,865 |
| Marketable Securities | 29,978 | 29,932 | N/A | N/A | N/A |
| Receivables | 10,198 | 11,475 | 12,095 | 12,051 | 9,141 |
| Inventories | 12,652 | 11,007 | 9,258 | 8,185 | 7,784 |
| TOTAL | $70,582 | $71,341 | $69,883 | $70,302 | $68,765 |
| Non-Current Assets | |||||
| PPE Net | 16,585 | 15,625 | 14,463 | 14,506 | 14,482 |
| Intangibles | 7,696 | 7,767 | 7,845 | 7,912 | 7,990 |
| Other Non-Current Assets | 18,828 | 18,890 | 19,840 | 20,783 | 21,301 |
| TOTAL | $43,109 | $42,282 | $42,148 | $43,201 | $43,773 |
| Total Assets | $113,691 | $113,623 | $112,031 | $113,503 | $112,538 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 7,000 | 7,000 | 7,000 | 7,000 |
| Accounts payable and accrued liabilities | 8,123 | 6,014 | 4,432 | 7,842 | 8,503 |
| Accrued Expenses | 14,301 | 12,528 | 14,589 | 14,513 | 12,833 |
| Other current liabilities | 233 | 230 | 248 | 287 | 344 |
| TOTAL | $26,076 | $29,214 | $29,949 | $33,608 | $32,801 |
| Non-Current Liabilities | |||||
| Long Term Debt | 4,356 | 4,390 | 4,428 | 4,447 | 4,485 |
| Other Non-Current Liabilities | 14,673 | 15,052 | 15,865 | 16,430 | 16,871 |
| TOTAL | $19,029 | $19,442 | $20,293 | $20,877 | $21,356 |
| Total Liabilities | $45,105 | $48,656 | $50,242 | $54,485 | $54,157 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 48,472 | 48,472 | 48,229 | 47,895 | 47,895 |
| Common Shares | 485 | 485 | 482 | 479 | 479 |
| Retained earnings | -270,377 | -273,645 | -275,651 | -277,953 | -278,252 |
| Other shareholders' equity | 1,352 | 1,268 | 1,270 | 1,852 | 1,681 |
| TOTAL | $68,586 | $64,967 | $61,789 | $59,018 | $58,381 |
| Total Liabilities And Equity | $113,691 | $113,623 | $112,031 | $113,503 | $112,538 |